Home » Topics » BioWorld Science

BioWorld Science
RSS

Bayer discovers soluble guanylate cyclase activators

July 4, 2022

New antibacterials described by the Centre National de la Recherche Scientifique (CNRS)

July 4, 2022

FKBP51 blockade ameliorates cognitive function during obesity

July 4, 2022

ENT1 inhibitor reverses sporadic Alzheimer's disease in mice

July 1, 2022

Sutro Biopharma generates hemiasterlin/TLR agonist dual-conjugate anti-FolR-alpha ADCs

July 1, 2022

Anti-alpha-1-antitrypsin BMN-349 reverses liver disease in a preclinical model

July 1, 2022

China NMPA approves IND for Henlius' anti-TIGIT Fc fusion protein HLX-53

July 1, 2022

Ildong licenses Twist VHH antibody libraries for antibody discovery in immuno-oncology

July 1, 2022

Extended funding supports Errium's development of therapeutics for chronic autoimmune diseases

July 1, 2022

CSF1R inhibition could delay muscular dystrophy progression

July 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...